INOVIQ Ltd (ASX:IIQ)
Australia · Delayed Price · Currency is AUD 0.1750
+0.0100 (6.06%)
Aug 27, 2026, 3:59 PM AEST
INOVIQ Market Cap
INOVIQ has a market cap or net worth of 24.64 million as of August 27, 2026. Its market cap has decreased by -44.83% in one year.
Market Cap
24.64M
Enterprise Value
15.28M
Revenue
2.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
ChartMarket Cap Chart
Since June 20, 2016, INOVIQ's market cap has increased from 13.25M to 24.64M, an increase of 85.96%. That is a compound annual growth rate of 6.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 24.64M | -54.84% |
| Dec 31, 2025 | 54.55M | -5.02% |
| Dec 31, 2024 | 57.44M | -6.14% |
| Dec 29, 2023 | 61.19M | 3.91% |
| Dec 30, 2022 | 58.89M | -46.44% |
| Dec 31, 2021 | 109.96M | 102.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 521.83M |
| Healius | 308.62M |
| Monash IVF Group | 261.06M |
| Cryosite | 61.01M |
| Microba Life Sciences | 39.44M |
| Rhythm Biosciences | 34.68M |
| BCAL Diagnostics | 22.12M |
| Genetic Signatures | 19.76M |